RFL
NYSE · Pharmaceuticals
Rafael Holdings Inc-Class B
$1.28
+0.01 (+0.79%)
Open$1.28
Previous Close$1.27
Day High$1.32
Day Low$1.27
52W High$3.19
52W Low$1.12
Volume—
Avg Volume94.0K
Market Cap66.07M
P/E Ratio—
EPS$-0.78
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.64M | 1.25M | 15.20M |
| Net Income | -54,486,235 | -37,496,262 | 4.84M |
| Profit Margin | -3,328.2% | -3,161.8% | 31.9% |
| EBITDA | -50,990,932 | -37,040,361 | 7.34M |
| Free Cash Flow | — | — | 4.44M |
| Rev Growth | +30.8% | +30.8% | +5.7% |
| Debt/Equity | 0.01 | 0.01 | 0.33 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |